Bevacizumab and Vasoconstriction

NCT00929058 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Cancer

Interventions

DRUG: Bevacizumab

Sponsor

Radboud University Medical Center